Chirag Potdar
About Chirag Potdar
Chirag Potdar serves as the Scientific Marketing and Communications Manager at Virica Biotech in Toronto, Ontario, Canada, a position he has held since 2022. He holds a Global MBA from The Johns Hopkins University and has a background in biotechnology and marketing, with previous roles at Lupin Pharmaceuticals and Mailhem Ikos Environment Pvt. Ltd.
Work at Virica Biotech
Chirag Potdar serves as the Scientific Marketing and Communications Manager at Virica Biotech, a position he has held since 2022. Based in Toronto, Ontario, Canada, he is responsible for developing and implementing marketing strategies that communicate the scientific advancements of the company. His role involves collaboration with various teams to ensure that the messaging aligns with the company's objectives and resonates with the target audience.
Education and Expertise
Chirag Potdar holds a Global MBA from The Johns Hopkins University - Carey Business School, where he studied Business Administration and Management from 2016 to 2018. He also earned a Master of Science (MSc) in Biotechnology and Bioinformatics from the Institute of Bioinformatics and Biotechnology at the University of Pune, completing his studies from 2010 to 2015. His educational background equips him with a strong foundation in both business and scientific disciplines.
Professional Background
Chirag Potdar has a diverse professional background in the pharmaceutical and biotechnology sectors. Prior to his current role, he worked at Lupin Pharmaceuticals as a Product Manager from 2018 to 2019 and as a Brand Marketing Intern from 2017 to 2018. He also gained experience as a Technical Marketing Executive at Mailhem Ikos Environment Pvt. Ltd. from 2015 to 2016. His early career included internships at Johns Hopkins Medicine and Sanofi, where he contributed to clinical trials and marketing strategies.
Research and Clinical Trials Experience
Chirag Potdar has participated in significant research and clinical trials throughout his career. Notably, he assisted in the documentation procedures and monitoring protocols of Phase 2 and Phase 3 clinical trials during his internship at Sanofi India Ltd. He also worked on the clinical trial of the drug Lixisenatide, which was successfully completed and released into the market in 2015. His research efforts have focused on biodegradative studies in biochemistry.